HPV Vaccination

Additional Evidence HPV Vaccine Protects Against Cervical Cancer

Additional Evidence HPV Vaccine Protects Against Cervical Cancer

The vaccine against human papillomavirus (HPV) infection appears even more effective than previously believed and protection appears to occur even when only one or two of the recommended doses are given.

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

By

Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.

CDC: Most HPV-Linked Cancers Are Preventable

CDC: Most HPV-Linked Cancers Are Preventable

Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers.

More Than HPV Vaccine Uptake Is Needed to Reduce the Burden of HPV-associated Cancers

More Than HPV Vaccine Uptake Is Needed to Reduce the Burden of HPV-associated Cancers

By

Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.

Canadian Vaccination Programs Encouraged to Extend HPV Vaccine to Males

Canadian Vaccination Programs Encouraged to Extend HPV Vaccine to Males

By

An analysis has recommended expanding HPV vaccination programs to include males in Canada because it will help protect them against HPV-related cancers.

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

Oncologists should raise awareness of HPV-related cancers and role of vaccinations

Initiation of HPV Vaccination Highest Among High-poverty and Majority Hispanic Communities

Initiation of HPV Vaccination Highest Among High-poverty and Majority Hispanic Communities

By

Teen girls living in high-poverty and in majority Hispanic communities had the highest rates of having received at least 1 dose of the HPV vaccine compared with those in low-poverty communities and in communities of other racial or ethnic compositions.

Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination

Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination

By

Many pediatricians and primary care physicians reported communicating about HPV vaccination with parents in ways that likely discourage them from having their children vaccinated.

CDC: Not Enough Male Adolescents Receiving HPV Vaccine

CDC: Not Enough Male Adolescents Receiving HPV Vaccine

Physicians failing to recommend it or adequately explain its benefits to parents could be a factor.

Many Doctors Not Consistent With HPV Vaccine Recommendations

Many Doctors Not Consistent With HPV Vaccine Recommendations

A sizable minority of doctors does not strongly endorse HPV vaccination nor deliver timely recommendations.

Few U.S. states mandate HPV vaccination

Few U.S. states mandate HPV vaccination

Immunization protects against sexually transmitted disease and certain cancers, health experts say, but only two U.S. states mandate vaccination.

Polled parents see more benefits in vaccination

Polled parents see more benefits in vaccination

Reports on outbreaks of measles, pertussis in past year may have shifted opinions on vaccination.

Fatalism May Encourage Avoidance of HPV Vaccination

By

Fatalistic beliefs may affect completion of the human papillomavirus (HPV) vaccine series in some areas of the United States.

High-grade cervical lesions declining in young women

By

A decrease in cervical lesions among young women in the United States has been observed, but the cause for this drop is not proven.

9-Valent human papillomavirus (HPV) vaccine can potentially reduce cervical cancers by 80%

By

The newest human papillomavirus (HPV) vaccine can potentially prevent 80% of cervical cancers in the United States if given to children early enough, before they are exposed to the virus.

New HPV vaccine approved after international phase 2/3 trial

By

Trial data indicates that if populations are vaccinated with Gardasil 9, approximately 90% of all cervical cancers worldwide could be prevented.

HPV vaccination often administered at less beneficial age

HPV vaccination often administered at less beneficial age

Researchers note that CDC recommends vaccination at age 11 or 12, but only half of girls receiving the vaccination get it at the proper age.

FDA approves 9-valent HPV vaccine to prevent certain cancers

FDA approves 9-valent HPV vaccine to prevent certain cancers

The FDA has approved Gardasil 9 for the prevention of anal, cervical, vaginal, and vulvar cancers.

Cervical cancer incidence higher in states with lower proportion of HPV vaccination rates

Cervical cancer incidence higher in states with lower proportion of HPV vaccination rates

Number of adolescent girls receiving the human papillomavirus (HPV) vaccine much lower in states with higher rates of cervical cancer.

HPV vaccine could prevent most cervical cancers

HPV vaccine could prevent most cervical cancers

Research suggests the human papillomavirus (HPV) vaccine could prevent 90 percent of cervical malignancies.

HPV vaccine shows sustained efficacy, immunogenicity, and safety in long-term study

By

A long-term follow-up study shows the sustained efficacy, immunogenicity, and safety of GlaxoSmithKline's human papillomavirus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than 9 years, and vaccine efficacy (VE) against incident infection was 100%.

Before HPV vaccine, most oropharyngeal cancers HPV positive

Before HPV vaccine, most oropharyngeal cancers HPV positive

Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus (HPV), according to a study.

President's panel calls for increased HPV vaccine administration

President's panel calls for increased HPV vaccine administration

The HPV vaccine protects against cancers of the cervix, throat, rectum, and penis, but too few are receiving it.

One dose of HPV vaccine may be sufficient to prevent cervical cancer

By

Women vaccinated with one dose of a HPV vaccine had antibodies against the viruses that remained stable in their blood for 4 years, suggesting that a single dose of vaccine may be sufficient to generate long-term immune responses against new HPV infections, and ultimately cervical cancer.

Ob-Gyns encounter HPV vaccination barriers

Ob-Gyns encounter HPV vaccination barriers

HPV vaccination is widely offered but underused; many doctors continue to offer annual Pap smears.

Antiviral therapy may trigger some genetic variants of cervical cancer

By

A new understanding of the genetic process that can lead to cervical cancer may help improve diagnosis of potentially dangerous lesions for some women.

Fewer than one-third of U.S. teen girls vaccinated for HPV

Fewer than one-third of U.S. teen girls vaccinated for HPV

In 2010, 32 percent had received three doses of vaccine; incidence of some HPV-linked cancers up.

Public health initiatives for head and neck cancers

Public health initiatives for head and neck cancers

By

Based on the current literature associating human papillomavirus (HPV) with head and neck cancer, what public health initiatives need to be implemented?

Vaccine for existing HPV infection may thwart cervical cancer

A therapeutic vaccine for women who are already harboring human papillomavirus (HPV) appeared to fight cervical cancer in a small, phase 1 study.

What are the CDC recommendations for HPV vaccination?

By

What are the recommendations for administering the human papillomavirus vaccine?

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs